Lopinavir/r [lopinavir/ritonavir] plus saquinavir salvage therapy in HIV-infected children with NRTI [nucleoside reverse transcriptase inhibitors] and/or NNRTI [non nucleoside reverse transcriptase inhibitors] failure: PK [pharmacokinetics] and two-year treatment follow up
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Saquinavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics; Therapeutic Use
- 01 Apr 2015 NCT reports actual enrollment as 50, info retained as per results published.
- 04 Jun 2010 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 04 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.